Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging

Matthew F. Covington; Scott Sherman; Denise Lewis; Hong Lei; Elizabeth Krupinski; Phillip H. Kuo

doi:10.1371/journal.pone.0134457

Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging

Matthew F. Covington, Scott Sherman, Denise Lewis, Hong Lei, Elizabeth Krupinski, Phillip H. Kuo

Department of Radiology

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.

Original language	English
Article number	e0134457
Journal	PloS one
Volume	10
Issue number	7
DOIs	https://doi.org/10.1371/journal.pone.0134457
State	Published - Jul 30 2015

Access to Document

10.1371/journal.pone.0134457

Cite this

@article{af6d7f0dee4f431d8de2add2496479a9,

title = "Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging",

abstract = "Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.",

author = "Covington, {Matthew F.} and Scott Sherman and Denise Lewis and Hong Lei and Elizabeth Krupinski and Kuo, {Phillip H.}",

note = "Publisher Copyright: {\textcopyright} 2015 Covington et al.",

year = "2015",

month = jul,

day = "30",

doi = "10.1371/journal.pone.0134457",

language = "English",

volume = "10",

journal = "PloS one",

issn = "1932-6203",

number = "7",

}

TY - JOUR

T1 - Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging

AU - Covington, Matthew F.

AU - Sherman, Scott

AU - Lewis, Denise

AU - Lei, Hong

AU - Krupinski, Elizabeth

AU - Kuo, Phillip H.

PY - 2015/7/30

Y1 - 2015/7/30

N2 - Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.

AB - Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.

UR - http://www.scopus.com/inward/record.url?scp=84941966191&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0134457

DO - 10.1371/journal.pone.0134457

M3 - Article

C2 - 26226362

AN - SCOPUS:84941966191

SN - 1932-6203

VL - 10

JO - PloS one

JF - PloS one

IS - 7

M1 - e0134457

ER -

Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging

Abstract

Access to Document

Other files and links

Fingerprint

Cite this